Açikgöz O, Gönenç S, Kayatekin BM, Uysal N, Pekçetin Ç, Şemin I, Güre A (1998) Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum. Brain Res 813:200–202

Al-Amri JS, Hagras MM, Mujallid MI (2013) Effect of epigallocatechin-3-gallate on inflammatory mediators release in LPS- induced Parkinson's disease in rats. Indian J Exp Biol 52:357–362

Barayuga SM, Pang X, Andres MA, Panee J, Bellinger FP (2013) Methamphetamine decreases levels of glutathione peroxidases 1 and 4 in SH-SY5Y neuronal cells: protective effects of selenium. Neurotoxicology. 37:240–246

Brigelius-Flohé R (2006) Glutathione peroxidases and redox-regulated transcription factors. Biol Chem 387:1329–1335

Cadet JL, Brannock C (1998) Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 32:117–131

Cadet JL, Sheng P, All S, Rothman R, Carlson E, Epstein C (1994) Rapid communication: attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem 62:380–383

Cadet JL, Jayanthi S, Deng X (2003) Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J 17:1775–1788

Chandramani Shivalingappa P, Jin H, Anantharam V, Kanthasamy A, Kanthasamy A (2012) N-acetyl cysteine protects against methamphetamine-induced dopaminergic neurodegeneration via modulation of redox status and autophagy in dopaminergic cells. Parkinsons Dis 2012:424285

Chen HM, Lee YC, Huang CL, Liu HK, Liao WC, Lai WL, Lin YR, Huang NK (2007) Methamphetamine downregulates peroxiredoxins in rat pheochromocytoma cells. Biochem Biophys Res Commun 354:96–101

Cubells JF, Rayport S, Rajendran G, Sulzer D (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 14:2260–2271

De Vito MJ, Wagner GC (1989) Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology. 28:1145–1150

Fukami G, Hashimoto K, Koike K, Okamura N, Shimizu E, Iyo M (2004) Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine. Brain Res 1016:90–95

Fumagalli F, Gainetdinov RR, Wang Y-M, Valenzano KJ, Miller GW, Caron MG (1999) Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 Knock-out mice. J Neurosci 19:2424–2431

Gluck MR, Moy LY, Jayatilleke E, Hogan KA, Manzino L, Sonsalla PK (2001) Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J Neurochem 79:152–160

Harold C, Wallace T, Friedman R, Gudelsky G, Yamamoto B (2000) Methamphetamine selectively alters brain glutathione. Eur J Pharmacol 400:99–102

Hashimoto K, Tsukada H, Nishiyama S, Fukumoto D, Kakiuchi T, Shimizu E, Iyo M (2004) Protective effects of N-acetyl-L-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine. Neuropsychopharmacology. 29:2018–2023

Hirata H, Ladenheim B, Carlson E, Epstein C, Cadet JL (1996) Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res 714:95–103

Hom DG, Jiang D, Hong E-J, Mo JQ, Andersen JK (1997) Elevated expression of glutathione peroxidase in PC12 cells results in protection against methamphetamine but not MPTP toxicity. Mol Brain Res 46:154–160

Horner KA, Gilbert YE, Cline SD (2011) Widespread increases in malondialdehyde immunoreactivity in dopamine-rich and dopamine-poor regions of rat brain following multiple, high doses of methamphetamine. Front Syst Neurosci 5:27

Hotchkiss AJ, Gibb JW (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214:257–262

Huang MC, Lin SK, Chen CH, Pan CH, Lee CH, Liu HC (2013) Oxidative stress status in recently abstinent methamphetamine abusers. Psychiatry Clin Neurosci 67:92–100

Iversen L (2006) Neurotransmitter transporters and their impact on the development of psychopharmacology. Br J Pharmacol 147:S82–S88

Jang Eun Y, Yang Chae H, Hedges David M, Kim Soo P, Lee Jun Y, Ekins Tyler G, Garcia Brandon T, Kim Hee Y, Nelson Ashley C, Kim Nam J, Steffensen Scott C (2016) The role of reactive oxygen species in methamphetamine self-administration and dopamine release in the nucleus accumbens. Addict Biol 22:1304–1315

Jayanthi S, Ladenheim B, Cadet JL (1998) Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Ann N Y Acad Sci 844:92–102

Johnson Z, Venters J, Guarraci FA, Zewail-Foote M (2015) Methamphetamine induces DNA damage in specific regions of the female rat brain. Clin Exp Pharmacol Physiol 42:570–575

Kate M-D, John PK (2017) The role of oxidative stress in methamphetamine-induced toxicity and sources of variation in the Design of Animal Studies. Curr Neuropharmacol 15:300–314

Kogan FJ, Nichols WK, Gibb JW (1976) Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur J Pharmacol 36:363–371

Koriem KM, Abdelhamid AZ, Younes HF (2013) Caffeic acid protects tissue antioxidants and DNA content in methamphetamine induced tissue toxicity in Sprague Dawley rats. Toxicol Mech Methods 23:134–143

Krasnova IN, Cadet JL (2009) Methamphetamine toxicity and messengers of death. Brain Res Rev 60:379–407

Lau JWS, Senok S, Stadlin A (2000) Methamphetamine-induced oxidative stress in cultured mouse astrocytes. Ann N Y Acad Sci 914:146–156

LaVoie MJ, Hastings TG (1999) Dopamine Quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci 19:1484–1491

Li YM, Chan HY, Huang Y, Chen ZY (2007) Green tea catechins upregulate superoxide dismutase and catalase in fruit flies. Mol Nutr Food Res 51:546–554

Lin A, Chyi B, Wu L, Hwang L, Ho L (1998) The antioxidative property of green tea against iron-induced oxidative stress in rat brain. Chin J Phys 41:189–194

Lin Y-S, Tsai Y-J, Tsay J-S, Lin J-K (2003) Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J Agric Food Chem 51:1864–1873

Lin L-C, Wang M-N, Tseng T-Y, Sung JS, Tsai TH (2007) Pharmacokinetics of (−)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution. J Agric Food Chem 55:1517–1524

Liu Q, Hazan A, Eaton MJ, Soliman KF, Angulo JA (2014) Protection against methamphetamine-induced striatal apoptosis by Epigallocatechin Gallate (EGCG) in the mouse brain. J Drug Alcohol Res 3:1–8

Liu Q, Hazan A, Grinman E, Angulo JA (2017) Pharmacological activation of the neurotensin receptor 1 abrogates the methamphetamine-induced striatal apoptosis in the mouse brain. Brain Res 1659:148–155

Mandel S, Weinreb O, Amit T, Youdim Moussa BH (2004) Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (−)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J Neurochem 88:1555–1569

Mandel SA, Avramovich-Tirosh Y, Reznichenko L, Zheng H, Weinreb O, Amit T, Youdim MBH (2005) Multifunctional activities of green tea catechins in neuroprotection. Neurosignals. 14:46–60

Ng T-P, Feng L, Niti M, Kua E-H, Yap K-B (2008) Tea consumption and cognitive impairment and decline in older Chinese adults. Am J Clin Nutr 88:224–231

Pervin M, Unno K, Nakagawa A, Takahashi Y, Iguchi K, Yamamoto H, Hoshino M, Hara A, Takagaki A, Nanjo F, Minami A, Imai S, Nakamura Y (2017) Blood brain barrier permeability of (−)-epigallocatechin gallate, its proliferation-enhancing activity of human neuroblastoma SH-SY5Y cells, and its preventive effect on age-related cognitive dysfunction in mice. Biochem Biophys Rep 9:180–186

Pubill D, Chipana C, Camins A, Pallàs M, Camarasa J, Escubedo E (2005) Free radical production induced by methamphetamine in rat striatal synaptosomes. Toxicol Appl Pharmacol 204:57–68

Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP, Riceevans C (1995) Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 322:339–346

Seiler A, Schneider M, Forster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Radmark O, Wurst W, Bornkamm GW, Schweizer U, Conrad M (2008) Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab 8:237–248

Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H (1998) Wide distribution of [3H](−)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogensis. 19:1771–1776

Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406–433

Thomas DM, Francescutti-Verbeem DM, Kuhn DM (2008) The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity. J Neurochem 105:605–616

Tian W, Han XG, Liu YJ, Tang GQ, Liu B, Wang YQ, Xiao B, Xu YF (2013) Intrathecal epigallocatechin gallate treatment improves functional recovery after spinal cord injury by upregulating the expression of BDNF and GDNF. Neurochem Res 38:772–779

United Nations Office on Drugs and Crime (2016) World drug report 2016. United Nations Publication

Wagner GC, Carelli RM, Jarvis MF (1985) Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res Commun Chem Pathol Pharmacol 47:221–228

Walker J, Winhusen T, Storkson JM, Lewis D, Pariza MW, Somoza E, Somoza V (2014) Total antioxidant capacity is significantly lower in cocaine-dependent and methamphetamine-dependent patients relative to normal controls: results from a preliminary study. Human psychopharmacology 29:537–543

Weinreb O, Mandel S, Amit T, Youdim MBH (2004) Neurological mechanisms of green tea polyphenols in Alzheimer’s and Parkinson’s diseases. J Nutr Biochem 15:506–516

Weinreb O, Amit T, Mandel S, Youdim MB (2009) Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr 4:283–296

Wells PG, Bhuller Y, Chen CS, Jeng W, Kasapinovic S, Kennedy JC, Kim PM, Laposa RR, McCallum GP, Nicol CJ, Parman T, Wiley MJ, Wong AW (2005) Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species. Toxicol Appl Pharmacol 207:354–366

Yamamoto BK, Bankson MG (2005) Amphetamine neurotoxicity: cause and consequence of oxidative. Stress 17:87–118

Yamamoto BK, Moszczynska A, Gudelsky GA (2010) Amphetamine toxicities. Ann N Y Acad Sci 1187:101–121

Zhang X, Tobwala S, Ercal N (2012) N-acetylcysteine amide protects against methamphetamine-induced tissue damage in CD-1 mice. Hum Exp Toxicol 31:931–944